IP Library › Granted Patent US 12,553,860
Granted Patent B2
US 12,553,860 · App. 18/587,733 · Granted Feb 17, 2026

Biochemical analysis instrument

Inventors: Clive Gavin Brown (Oxford, GB); James Peter Willcocks (Oxford, GB)
Assignee: Oxford Nanopore Technologies PLC
G01N27/44756C12Q1/6869G01N33/48721G01N15/1433G01N15/1459
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,553,860
App. No.
18/587,733
Granted
Feb 17, 2026
Kind
B2
Abstract

An analysis instrument comprises plural modules connected together over a data network, each module comprising an analysis apparatus operable to perform biochemical analysis of a sample. Each module comprises a control unit that controls the operation of the analysis apparatus. The control units are addressable to select an arbitrary number of modules to operate as a cluster for performing a common biochemical analysis. The control units communicate over the data network, repeatedly during the performance of the common biochemical analysis, to determine the operation of the analysis apparatus of each module required to meet the global performance targets, on the basis of measures of performance derived from the output data produced by the modules. The arrangement of the instrument as modules interacting in this manner provides a scalable analysis instrument.

Claims (10)

1 . A method for supplying sample into a nanopore sensor device comprising a plurality of nanopores, the method comprising automatically controlling a fluidics system mounted on a body to supply sample from a reservoir mounted on the body to an inlet of the sensor device;

wherein the fluidics system comprises supply channels and inlet pumps configured for pumping fluids from reservoirs, including the reservoir, to the sensor device;

wherein the fluidics system comprises an output pump configured for pumping fluids out of the sensor device through an outlet channel connected to a waste reservoir configured for disposal of the fluids; and

wherein the fluidics system comprises a selector valve disposed in supply channels between the inlet pumps connected to the reservoirs and the output pump, wherein the selector valve is configured to selectively connect the sensor device to the reservoirs, and wherein the selector valve is configured to selectively connect the sensor device to the waste reservoir.

2 . The method of claim 1 , wherein automatically controlling the fluidics system comprises automatically controlling the fluidics system using a controller to supply sample from a reservoir mounted on the body to an inlet of the sensor device.

3 . The method of claim 2 , wherein the controller is controlled by a control module that is implemented in an embedded computer by software executed thereon.

4 . The method of claim 1 , wherein the body is configured for attachment of a well plate, which may be filled with samples.

5 . The method of claim 1 , wherein the sample comprises an analyte selected from the group consisting of DNA, RNA, polynucleotides, protein, and small molecule.

6 . The method of claim 1 , wherein the sensor device comprises a sensor device body in which there is formed a plurality of recesses, each recess having an electrode arranged therein, wherein an amphiphilic membrane is formed across each recess and each of the plurality of nanopores is inserted into the amphiphilic membrane across a corresponding recess.

7 . The method of claim 6 , wherein the sensor device body is covered by a cover that extends over the sensor device body and is hollow to define a chamber into which each recess opens, wherein a common electrode is disposed within the chamber outside of the recesses.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2024
From: BROWN, CLIVE GAVIN; WILLCOCKS, JAMES PETER
To: OXFORD NANOPORE TECHNOLOGIES LIMITED
Reel/Frame 067401/0721 →
CHANGE OF NAME Recorded May 14, 2024
From: OXFORD NANOPORE TECHNOLOGIES LIMITED
To: OXFORD NANOPORE TECHNOLOGIES PLC
Reel/Frame 067401/0944 →
Priority Claims (1)
GB 1016614 · Oct 1, 2010 · national
Continuity (7)
Continuation 17901113 · Sep 1, 2022
Continuation 16374703 · Apr 3, 2019
Continuation 15491450 · Apr 19, 2017
Continuation 14302303 · Jun 11, 2014
Continuation 13512937
Provisional Application 61265488 · Dec 1, 2009
Related Publication 20240248060A1 · Jul 25, 2024
References Cited (106)
US 4315432A · Newton · 1982 [cited by applicant]
US 4659920A · Nishiura et al. · 1987 [cited by applicant]
US 5386373A · Keeler et al. · 1995 [cited by applicant]
US 5694495A · Hara et al. · 1997 [cited by applicant]
US 7001792B2 · Sauer et al. · 2006 [cited by applicant]
US 7155344B1 · Parce et al. · 2006 [cited by applicant]
US 7501279B2 · Folch et al. · 2009 [cited by applicant]
US 7507575B2 · Bedingham et al. · 2009 [cited by applicant]
US 8461854B2 · Chen et al. · 2013 [cited by applicant]
US 8828208B2 · Canas et al. · 2014 [cited by applicant]
US 9057102B2 · Turner et al. · 2015 [cited by applicant]
US 9127313B2 · Brown et al. · 2015 [cited by applicant]
US 9546400B2 · Turner et al. · 2017 [cited by applicant]
US 9556480B2 · Turner et al. · 2017 [cited by applicant]
US 9651519B2 · Brown et al. · 2017 [cited by applicant]
US 9678056B2 · Turner et al. · 2017 [cited by applicant]
US 9738929B2 · Turner et al. · 2017 [cited by applicant]
US 10386330B2 · Brown et al. · 2019 [cited by applicant]
US 10788451B2 · Brown et al. · 2020 [cited by applicant]
US 11169113B2 · Brown et al. · 2021 [cited by applicant]
US 20020189945A1 · Ruggiero · 2002 [cited by applicant]
US 20030070923A1 · Schroeder et al. · 2003 [cited by applicant]
US 20030096418A1 · Yamazaki et al. · 2003 [cited by applicant]
US 20030096423A1 · Ryan et al. · 2003 [cited by applicant]
US 20040040868A1 · Denuzzio et al. · 2004 [cited by applicant]
US 20040055901A1 · Petersen et al. · 2004 [cited by applicant]
US 20050006372A1 · Murakami et al. · 2005 [cited by applicant]
US 20050127035A1 · Ling · 2005 [cited by applicant]
US 20060019247A1 · Su et al. · 2006 [cited by applicant]
US 20060073489A1 · Li et al. · 2006 [cited by applicant]
US 20060086626A1 · Joyce · 2006 [cited by applicant]
US 20060105461A1 · Tom-Moy et al. · 2006 [cited by applicant]
US 20060121624A1 · Huang et al. · 2006 [cited by applicant]
US 20060210995A1 · Joyce · 2006 [cited by examiner]
US 20070095671A1 · Kovacs · 2007 [cited by applicant]
US 20070099191A1 · Nair et al. · 2007 [cited by applicant]
US 20070202008A1 · Schembri · 2007 [cited by examiner]
US 20070218471A1 · Kim et al. · 2007 [cited by applicant]
US 20080014114A1 · Van Atta · 2008 [cited by examiner]
US 20080069739A1 · Ludwig · 2008 [cited by applicant]
US 20090167288A1 · Reid et al. · 2009 [cited by applicant]
US 20090283412A1 · Sansinena et al. · 2009 [cited by applicant]
US 20090298072A1 · Ju · 2009 [cited by applicant]
US 20100035260A1 · Olasagasti et al. · 2010 [cited by applicant]
US 20100196203A1 · Sanghera et al. · 2010 [cited by applicant]
US 20100276588A1 · Syms · 2010 [cited by applicant]
US 20100331194A1 · Turner et al. · 2010 [cited by applicant]
US 20110053284A1 · Meller et al. · 2011 [cited by applicant]
US 20110120871A1 · Reid et al. · 2011 [cited by applicant]
US 20110202280A1 · Sikora et al. · 2011 [cited by applicant]
US 20110270533A1 · Zhang et al. · 2011 [cited by applicant]
US 20110287414A1 · Chen et al. · 2011 [cited by applicant]
US 20120322679A1 · Brown et al. · 2012 [cited by applicant]
US 20130045872A1 · Zhou et al. · 2013 [cited by applicant]
US 20130071837A1 · Winters-Hilt et al. · 2013 [cited by applicant]
US 20130078624A1 · Holmes et al. · 2013 [cited by applicant]
US 20130090248A1 · Link et al. · 2013 [cited by applicant]
US 20140296083A1 · Brown et al. · 2014 [cited by applicant]
US 20140296089A1 · Holmes et al. · 2014 [cited by applicant]
US 20140308661A1 · Holmes et al. · 2014 [cited by applicant]
US 20140329693A1 · Reid et al. · 2014 [cited by applicant]
US 20140346059A1 · Akeson · 2014 [cited by applicant]
US 20150066385A1 · Schnall-Levin et al. · 2015 [cited by applicant]
US 20150346149A1 · Brown et al. · 2015 [cited by applicant]
US 20160040230A1 · Akeson · 2016 [cited by applicant]
US 20170350859A1 · Brown et al. · 2017 [cited by applicant]
US 20190064109A1 · Brown et al. · 2019 [cited by applicant]
US 20190204267A1 · Brown et al. · 2019 [cited by applicant]
US 20190265193A1 · Brown et al. · 2019 [cited by applicant]
US 20200110752A1 · Smith et al. · 2020 [cited by applicant]
US 20230243777A1 · Brown et al. · 2023 [cited by applicant]
EP 1965210A1 · 2008 [cited by applicant]
GB 2430763A · 2007 [cited by applicant]
JP H1062426A · 1998 [cited by applicant]
JP 3668799B2 · 2005 [cited by applicant]
WO WO199801758A1 · 1998 [cited by applicant]
WO WO200225934A2 · 2002 [cited by applicant]
WO WO200229402A2 · 2002 [cited by applicant]
WO WO2008042018A2 · 2008 [cited by applicant]
WO WO2008102120A1 · 2008 [cited by applicant]
WO WO2009022152A1 · 2009 [cited by applicant]
WO WO2009077734A2 · 2009 [cited by applicant]
WO WO2010062913A2 · 2010 [cited by applicant]
WO WO2010122293A1 · 2010 [cited by applicant]
WO WO2011067559A1 · 2011 [cited by applicant]
WO WO2018170552A1 · 2018 [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/GB2014/053121, mailed Feb. 24, 2015. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/GB2014/053121, mailed Apr. 28, 2016. [cited by applicant]
[No Author Listed] Helicos BioSciences Corporation, “Helicos Genetic Analysis System,” Specification Sheet retrieved online at: www.helicosbio.com/Portals/O/Documents/Helicos_SalesSpec.pdf, 4 pages (2008). [cited by applicant]
Audet, Yves et al., Yield Improvement of a Large Area Magnetic Field Sensor Array Using Redundancy Schemes. IEEE Transactions on Very Large Scale Integration (VLSI) Systems. 1997;5(1):28-33. [cited by applicant]
Branton et al., The potential and challenges of nanopore sequencing. Nat Biotechnol. Oct. 2008;26(10):1146-53. doi:10.1038/nbt.1495. [cited by applicant]
Case 1:17-cv-00275-LPS Document 18. Notice of subsequent events relating to Oxford's motion to dismiss (D.I. 9). Oct. 18, 2017. [cited by applicant]
Case 1:17-cv-00275-LPS Document 19. Oxford Nanopore Technologies, Inc.'s response to Pacific Biosciences of California, Inc.'s notice of subsequent events. Oct. 24, 2017. [cited by applicant]
Case 1:17-cv-00275-RGA Document 10. Oxford's opening brief in support of its motion to dismiss PacBio's complaint for patent infringement. May 8, 2017. [cited by applicant]
Case 1:17-cv-00275-RGA Document 14. PacBio's response to Oxford's motion to dismiss. Jun. 5, 2017. [cited by applicant]
Case 1:17-cv-00275-RGA Document 16. Oxford's reply brief in support of its motion to dismiss PacBio's complaint for patent infringement. Jun. 26, 2017. [cited by applicant]
Case 1:17-cv-01353-LPS Document 13. First Amended Complaint for Patent Infringement. Nov. 30, 2017. [cited by applicant]
Case 1:17-cv-01353-LPS Document 15. Plaintiff's response to Oxford Nanopore Technologies, Inc.'s Motion to Dismiss and Request for Scheduling Conference. Nov. 30, 2017. [cited by applicant]
Case 1:17-cv-01353-RGA Document 10. Oxford's opening brief in support of its motion to partially dismiss Pacbio's complaint for patent infringement. Nov. 16, 2017. [cited by applicant]
EP Opposition against EP 2422198 B1 dated Jul. 7, 2014. [cited by applicant]
Inman et al., A high-throughput distributed DNA sequence analysis and database system. IBM Systems Journal, vol. 40(2):464-486 (2001). [cited by applicant]
Jetha et al., Forming an alpha-hemolysin nanopore for single-molecule analysis. Methods Mol Biol. 2009;544:113-27. doi: 10.1007/978-1-59745-483-4_9. [cited by applicant]
Liu et al. Integrated microfluidic CustomArray device for bacterial genotyping and dentification. JALA (2006) 11 360-367. (Year: 2006). [cited by applicant]
Rhee et al., Nanopore sequencing technology: research trends and applications. Trends Biotechnol. Dec. 2006;24(12):580-6. Epub Oct. 19, 2006. [cited by applicant]
United States District Court for the District of Delaware Order. [cited by applicant]
Zagnoni et al., Microfluidic array platform for simultaneous lipid bilayer membrane formation. Biosens Bioelectron. Jan. 1, 2009;24(5):1235-40. doi: 10.1016/j.bios.2008.07.022. Epub Jul. 23, 2008. [cited by applicant]